At Daroo Darman Parmis, we are staunch advocates for local manufacturing, boasting state-of-the-art facilities that produce high-quality medical devices, Dietary supplements, and pharmaceuticals.
Medical Device Facility
Spanning 6,000 square meters, this GMP- and ISO-certified facility produces high-quality surgical sutures, wound dressings, surgical mesh, catheters and guidewires for cardiology and urology. It features 400 m² ISO Class 7 and 400 m² ISO Class 8 Cleanrooms, as well as an advanced quality control lab for physical, chemical, and microbial testing. Teams of engineers and technicians continuously refine processes to deliver innovative solutions and ensure patient safety.
Pharmaceutical Facility
At two times the size of the medical device facility, this GMP- and ISO-certified subsidiary specializes in large-scale production and advanced research. A robust quality framework guarantees safety, efficacy, and regulatory compliance, while ongoing improvements drive growth in product portfolios and patient outcomes. Through these subsidiaries, DDP remains committed to elevating healthcare standards and fostering innovation.
For nearly 50 years, members of Daroo Darman Parmis Group have been within the advanced medical care and well-developed private healthcare sector. As a prestigious investment entity, Daroo Darman Parmis, specializing in medical devices and pharmaceuticals, we leverage our extensive experience, unparalleled expertise, and forward-thinking vision to enhance healthcare standards. Our esteemed reputation is grounded in trust, superior quality, and exceptional performance, establishing us as a cornerstone of reliability in the healthcare sector.
Daroo Darman Parmis (DDP) is a leading healthcare investment firm in Iran, specializing in pharmaceuticals, medical devices, and related industries. While DDP is relatively new, it draws on the extensive legacy of its subsidiary companies—some of which have been serving the Iranian healthcare market for nearly half a century. This foundation enables us to maintain a forward-thinking vision aimed at enhancing healthcare standards.
Daroo Darman Parmis (DDP) as a leading Iranian holding specialized in the import, production, and in-licensing of medical devices, pharmaceuticals, nutraceuticals, Active Pharmaceuticals (API) and excipients tracing its origins back to 1979 through the import of general medical devices. DDP was formally established in 2016 and now supervises several subsidiaries under its umbrella.
We are proud of our network of high-performing subsidiaries that make significant contributions to the healthcare industry. These companies are recognized as industry leaders, continually setting benchmarks for excellence and innovation.
Collectively, our subsidiaries create a powerful ecosystem that not only drives growth and fosters innovation but also ensures the consistent delivery of world-class healthcare solutions nationwide.
Benefiting from OFAC clearance and strong collaborations with various companies around the world including American, European and Asian partners, DDP brings world-class products and raw materials into Iran’s healthcare market. The group maintains GMP and ISO certifications, ensuring the highest levels of safety, quality, and compliance.
DDP’s extensive portfolio encompasses disposable and hospital-based medical devices, various pharmaceutical products (including in-licensed formulations), nutraceuticals, and numerous categories such as vascular access, cardiac care, airway management, surgery, wound care, and mother-baby products. By emphasizing strategic logistics, innovation, and exceptional customer service, DDP has become a trusted supplier in Iran’s healthcare sector.
With a mission to elevate healthcare standards through long-term partnerships and value-driven solutions, DDP continually expands its global network. The company’s vision focuses on delivering sustainable innovations that reduce the burden on customers, enabling better outcomes for healthcare providers and patients alike.
Establishment of main member of the group “Iran Pharmis”
Importing the first disposable medical products: sterile hypodermic needles.
Beginning a partnership with Japanese companies to import medical adhesives.
Starting cooperation with American companies to import ostomy pouches.
Introducing advanced wound care dressings for the first time to Iran Market
Developing the activities by establishment of a new company to focus on general medical equipment portfolio.
Construction of our first production facility to produce surgical sutures and wound dressings.
Acquiring several small businesses, active in healthcare sector
Buying major share of a newly established pharmaceutical company and stepped into the drug industry.
Establishment of national drug distribution company
Signing contract with an Irish company to import Urology medical products
Beginning the cooperation with and American company to import all types of medical gloves
Obtaining ISO9001 and ISO13485 certificates
Adding vascular access and hemodialysis catheters products to our portfolio in cooperation with a well-known American company
Import of specialized urology , surgery products and anesthesia-respiratory
Establishment of pharmaceutical company and presenting supplement for hair loss treatment and infertility treatment
Daroo Darman Parmis was officially formed
Acquiring a new company with focus on import of home-care, maternal and pediatric medical products.
Starting construction of our new facility in two phases to produce General and Hazardous solid pharmaceutical and supplement products
Starting construction of our new facility in two phases to produce General and Hazardous solid pharmaceutical and supplement products
Adding a new line of business and entering to cosmetic market
Introduction and production of Mefenamic acid 500 for the first time in the country's pharmaceutical list, import of multivitamins for men (Androit) as the official representative of Qpharma Spain, formulation and production of infertility treatment products for women (Ovasitol and Irafertil), production of injectable famotidine / the pharmaceutical company has succeeded to gain knowledge-based approval from the vice president for Science and Technology.
Starting the licensed production of Pilfood products for women (after childbirth and menopause), import of the first Pilfood shampoo for oily scalp (pH6), production of Biotimed (Biotin) and Dexapamide (dexpanthenol) ampoules, and ranked as the 33 leading pharmaceutical companies in IRAN.
Starting the licensed production of Pillfood shampoos (anti-shedding, anti-dandruff and pH6 shampoos).
